Saudi Arabia dementia treatment market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

The Saudi Arabia dementia treatment market is valued at USD 70 million, projected to grow at 8% CAGR from 2019 to 2030, driven by rising dementia prevalence and advancements in treatments.

Region:Middle East

Author(s):Rebecca

Product Code:KRAA9450

Pages:87

Published On:November 2025

About the Report

Base Year 2024

Saudi Arabia Dementia Treatment Market Overview

  • The Saudi Arabia Dementia Treatment Market is valued at USD 70 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of dementia due to an aging population, rising awareness about mental health, and advancements in treatment options. The market is also supported by government initiatives aimed at improving healthcare infrastructure and access to dementia care services.
  • Key cities dominating the market includeRiyadh, Jeddah, and Dammam. Riyadh, as the capital, has a concentration of healthcare facilities and research institutions, while Jeddah and Dammam benefit from their strategic locations and access to a larger population base. These cities are pivotal in driving innovations and improving the quality of dementia care services.
  • In 2023, the Saudi government implemented a national dementia strategy aimed at enhancing the quality of care for dementia patients. This strategy includes the allocation of SAR 200 million for training healthcare professionals and establishing specialized dementia care units in hospitals across the country, ensuring better diagnosis and treatment options for patients. The operational framework for dementia care is governed by the “National Dementia Strategy, 2023” issued by the Ministry of Health, which mandates the establishment of specialized units, standardized diagnostic protocols, and ongoing professional training for compliance.
Saudi Arabia Dementia Treatment Market Size

Saudi Arabia Dementia Treatment Market Segmentation

By Indication:The market is segmented into various indications, including Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia, and Other Indications. Among these,Alzheimer’s Disease Dementiais the most prevalent, accounting for the largest portion of the market due to its high incidence rate and the growing awareness of the disease. The increasing number of diagnosed cases and the demand for effective treatment options are driving the growth of this segment.

Saudi Arabia Dementia Treatment Market segmentation by Indication.

By Treatment Type:The treatment options available in the market include Pharmacological Treatments, Non-Pharmacological Treatments, Support Services, and Others.Pharmacological Treatments, such as Cholinesterase Inhibitors and NMDA Antagonists, dominate the market due to their effectiveness in managing symptoms of dementia. The increasing adoption of these treatments, along with ongoing research and development, is expected to sustain their leading position in the market. Recent trends include the integration of combination therapies and pipeline drugs, as well as a growing emphasis on personalized medicine and telehealth solutions to improve patient outcomes.

Saudi Arabia Dementia Treatment Market segmentation by Treatment Type.

Saudi Arabia Dementia Treatment Market Competitive Landscape

The Saudi Arabia Dementia Treatment Market is characterized by a dynamic mix of regional and international players. Leading participants such as Pfizer Inc., Novartis AG, Eli Lilly and Company, Roche Holding AG, Johnson & Johnson, Merck & Co., Inc., AstraZeneca PLC, Biogen Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Sanofi S.A., AbbVie Inc., Eisai Co., Ltd., Daiichi Sankyo Co., Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Tabuk Pharmaceuticals Manufacturing Co., Jamjoom Pharma, Spimaco Addwaeih, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Cipla Ltd. contribute to innovation, geographic expansion, and service delivery in this space.

Pfizer Inc.

1849

New York, USA

Novartis AG

1996

Basel, Switzerland

Eli Lilly and Company

1876

Indianapolis, USA

Roche Holding AG

1896

Basel, Switzerland

Johnson & Johnson

1886

New Brunswick, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (Saudi Arabia dementia segment)

Market Share in Saudi Arabia Dementia Treatment Market

Number of Approved Dementia Drugs in Saudi Arabia

Patient Reach (Number of treated dementia patients annually)

Distribution Network Coverage (Saudi Arabia regions served)

Saudi Arabia Dementia Treatment Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Dementia:The aging population in Saudi Arabia is a significant driver of dementia cases, with projections indicating that by future, approximately 1.5 million individuals aged 65 and older will be living with dementia. This demographic shift is fueled by a life expectancy increase, which reached 76.5 years in future. As the population ages, the demand for effective dementia treatment options will continue to rise, necessitating enhanced healthcare services and resources.
  • Rising Awareness and Diagnosis Rates:Increased public awareness campaigns and educational initiatives have led to a notable rise in dementia diagnosis rates in Saudi Arabia. In future, the number of diagnosed dementia cases rose by 20%, reflecting improved recognition of symptoms and the importance of early intervention. This trend is supported by government efforts to promote mental health awareness, which is crucial for timely treatment and management of dementia-related conditions.
  • Advancements in Treatment Options and Technologies:The Saudi healthcare sector is witnessing significant advancements in dementia treatment technologies, including innovative pharmaceuticals and digital health solutions. In future, the introduction of at least five new dementia medications is anticipated, enhancing treatment efficacy. Additionally, the integration of telehealth services is expected to improve access to care, allowing patients to receive timely interventions and support from specialists, thereby improving overall treatment outcomes.

Market Challenges

  • Limited Access to Specialized Care Facilities:Access to specialized dementia care facilities remains a critical challenge in Saudi Arabia. As of future, there are only 30 dedicated dementia care centers across the country, serving a population of over 36 million. This shortage results in long waiting times for patients and families seeking care, ultimately hindering timely diagnosis and treatment, which can exacerbate the progression of the disease.
  • High Cost of Treatment and Medications:The financial burden associated with dementia treatment poses a significant challenge for many families in Saudi Arabia. The average annual cost of dementia care can exceed SAR 55,000 (approximately USD 14,600), which is unaffordable for a substantial portion of the population. This high cost limits access to necessary medications and therapies, leading to inadequate care and poorer health outcomes for patients.

Saudi Arabia Dementia Treatment Market Future Outlook

The future of the dementia treatment market in Saudi Arabia appears promising, driven by ongoing advancements in healthcare technology and increased government support. By future, the integration of digital health solutions and personalized medicine is expected to enhance patient care significantly. Furthermore, the collaboration between local healthcare providers and international organizations will facilitate the adoption of best practices, ultimately improving treatment efficacy and accessibility for dementia patients across the nation.

Market Opportunities

  • Development of Telemedicine Solutions:The rise of telemedicine presents a significant opportunity for enhancing dementia care in Saudi Arabia. By future, it is projected that telehealth services will increase by 45%, allowing patients to access specialized care remotely. This development can bridge the gap in care access, particularly for those in rural areas, ensuring timely interventions and ongoing support for patients and caregivers.
  • Expansion of Caregiver Support Programs:There is a growing need for caregiver support programs in Saudi Arabia, with an estimated 1.3 million informal caregivers currently providing care for dementia patients. By future, initiatives aimed at training and supporting these caregivers are expected to expand, enhancing their skills and reducing caregiver burnout. This expansion will improve the quality of care provided to patients and foster a more supportive environment for families.

Scope of the Report

SegmentSub-Segments
By Indication

Alzheimer’s Disease Dementia

Vascular Dementia

Lewy Body Dementia

Frontotemporal Dementia (FTD)

Parkinson Disease Dementia

Other Indications

By Treatment Type

Pharmacological Treatments (e.g., Cholinesterase Inhibitors, NMDA Antagonists)

Non-Pharmacological Treatments (e.g., Cognitive Stimulation Therapy, Occupational Therapy)

Support Services (e.g., Counseling, Social Support)

Others

By End-User

Hospitals

Home Care Providers

Nursing Homes

Rehabilitation Centers

Others

By Age Group

70 Years

80 Years

Years and Above

Others

By Treatment Setting

Inpatient Care

Outpatient Care

Community Care

Others

By Geographic Distribution

Central Region

Eastern Region

Western Region

Southern Region

Others

By Funding Source

Government Funding

Private Insurance

Out-of-Pocket Payments

Others

By Caregiver Type

Family Caregivers

Professional Caregivers

Volunteer Caregivers

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Pharmaceutical Manufacturers

Medical Device Manufacturers

Healthcare Providers and Hospitals

Health Insurance Companies

Non-Governmental Organizations (NGOs) focused on health

Clinical Research Organizations (CROs)

Players Mentioned in the Report:

Pfizer Inc.

Novartis AG

Eli Lilly and Company

Roche Holding AG

Johnson & Johnson

Merck & Co., Inc.

AstraZeneca PLC

Biogen Inc.

Amgen Inc.

Teva Pharmaceutical Industries Ltd.

Lundbeck A/S

Otsuka Pharmaceutical Co., Ltd.

Takeda Pharmaceutical Company Limited

Sanofi S.A.

AbbVie Inc.

Eisai Co., Ltd.

Daiichi Sankyo Co., Ltd.

Sun Pharmaceutical Industries Ltd.

Viatris Inc.

Hikma Pharmaceuticals PLC

Tabuk Pharmaceuticals Manufacturing Co.

Jamjoom Pharma

Spimaco Addwaeih

Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)

Cipla Ltd.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Dementia Treatment Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Dementia Treatment Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Dementia Treatment Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of dementia among the aging population
3.1.2 Rising awareness and diagnosis rates
3.1.3 Advancements in treatment options and technologies
3.1.4 Government initiatives and funding for dementia care

3.2 Market Challenges

3.2.1 Limited access to specialized care facilities
3.2.2 High cost of treatment and medications
3.2.3 Stigma associated with dementia
3.2.4 Shortage of trained healthcare professionals

3.3 Market Opportunities

3.3.1 Development of telemedicine solutions for remote care
3.3.2 Expansion of caregiver support programs
3.3.3 Investment in research and development for new therapies
3.3.4 Collaboration with international organizations for best practices

3.4 Market Trends

3.4.1 Growing adoption of digital health solutions
3.4.2 Increased focus on personalized medicine
3.4.3 Integration of mental health services with dementia care
3.4.4 Rise in community-based care models

3.5 Government Regulation

3.5.1 Implementation of national dementia strategies
3.5.2 Regulation of pharmaceutical pricing
3.5.3 Licensing requirements for dementia care facilities
3.5.4 Guidelines for caregiver training and support

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Dementia Treatment Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Dementia Treatment Market Segmentation

8.1 By Indication

8.1.1 Alzheimer’s Disease Dementia
8.1.2 Vascular Dementia
8.1.3 Lewy Body Dementia
8.1.4 Frontotemporal Dementia (FTD)
8.1.5 Parkinson Disease Dementia
8.1.6 Other Indications

8.2 By Treatment Type

8.2.1 Pharmacological Treatments (e.g., Cholinesterase Inhibitors, NMDA Antagonists)
8.2.2 Non-Pharmacological Treatments (e.g., Cognitive Stimulation Therapy, Occupational Therapy)
8.2.3 Support Services (e.g., Counseling, Social Support)
8.2.4 Others

8.3 By End-User

8.3.1 Hospitals
8.3.2 Home Care Providers
8.3.3 Nursing Homes
8.3.4 Rehabilitation Centers
8.3.5 Others

8.4 By Age Group

8.4.1 60-70 Years
8.4.2 71-80 Years
8.4.3 81 Years and Above
8.4.4 Others

8.5 By Treatment Setting

8.5.1 Inpatient Care
8.5.2 Outpatient Care
8.5.3 Community Care
8.5.4 Others

8.6 By Geographic Distribution

8.6.1 Central Region
8.6.2 Eastern Region
8.6.3 Western Region
8.6.4 Southern Region
8.6.5 Others

8.7 By Funding Source

8.7.1 Government Funding
8.7.2 Private Insurance
8.7.3 Out-of-Pocket Payments
8.7.4 Others

8.8 By Caregiver Type

8.8.1 Family Caregivers
8.8.2 Professional Caregivers
8.8.3 Volunteer Caregivers
8.8.4 Others

9. Saudi Arabia Dementia Treatment Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (Saudi Arabia dementia segment)
9.2.4 Market Share in Saudi Arabia Dementia Treatment Market
9.2.5 Number of Approved Dementia Drugs in Saudi Arabia
9.2.6 Patient Reach (Number of treated dementia patients annually)
9.2.7 Distribution Network Coverage (Saudi Arabia regions served)
9.2.8 R&D Investment in Dementia Therapies (annual spend)
9.2.9 Local Partnerships (with Saudi hospitals, clinics, or government)
9.2.10 Regulatory Approval Timeline (average time for SFDA approval)
9.2.11 Brand Recognition Score (Saudi healthcare sector)
9.2.12 Customer Retention Rate (Saudi institutional clients)
9.2.13 Pricing Strategy (relative to market average)
9.2.14 Product Portfolio Diversification (number of dementia-related products)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Pfizer Inc.
9.5.2 Novartis AG
9.5.3 Eli Lilly and Company
9.5.4 Roche Holding AG
9.5.5 Johnson & Johnson
9.5.6 Merck & Co., Inc.
9.5.7 AstraZeneca PLC
9.5.8 Biogen Inc.
9.5.9 Amgen Inc.
9.5.10 Teva Pharmaceutical Industries Ltd.
9.5.11 Lundbeck A/S
9.5.12 Otsuka Pharmaceutical Co., Ltd.
9.5.13 Takeda Pharmaceutical Company Limited
9.5.14 Sanofi S.A.
9.5.15 AbbVie Inc.
9.5.16 Eisai Co., Ltd.
9.5.17 Daiichi Sankyo Co., Ltd.
9.5.18 Sun Pharmaceutical Industries Ltd.
9.5.19 Viatris Inc.
9.5.20 Hikma Pharmaceuticals PLC
9.5.21 Tabuk Pharmaceuticals Manufacturing Co.
9.5.22 Jamjoom Pharma
9.5.23 Spimaco Addwaeih
9.5.24 Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
9.5.25 Cipla Ltd.

10. Saudi Arabia Dementia Treatment Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Dementia Care
10.1.2 Procurement Processes and Regulations
10.1.3 Preferred Vendors and Suppliers
10.1.4 Evaluation Criteria for Bids

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Dementia Care Facilities
10.2.2 Funding for Research and Development
10.2.3 Expenditure on Training Programs
10.2.4 Partnerships with NGOs

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges Faced by Hospitals
10.3.2 Issues Encountered by Home Care Providers
10.3.3 Difficulties for Nursing Homes
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels Among Caregivers
10.4.2 Training Needs Assessment
10.4.3 Technology Adoption Readiness
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Treatment Outcomes
10.5.2 Cost-Benefit Analysis of Care Models
10.5.3 Expansion of Services Offered
10.5.4 Others

11. Saudi Arabia Dementia Treatment Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from health organizations and government health ministries in Saudi Arabia
  • Review of academic journals and articles focusing on dementia treatment methodologies and market trends
  • Examination of demographic data and health statistics from the Saudi Arabian General Authority for Statistics

Primary Research

  • Interviews with neurologists and geriatric specialists involved in dementia care
  • Surveys conducted with healthcare providers and institutions offering dementia treatment services
  • Focus groups with caregivers and families of dementia patients to understand treatment experiences and needs

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including healthcare expenditure reports and patient registries
  • Triangulation of qualitative insights from interviews with quantitative data from surveys
  • Sanity checks through expert panel reviews comprising healthcare professionals and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on national healthcare spending on dementia
  • Segmentation of the market by treatment type, including pharmacological and non-pharmacological interventions
  • Incorporation of government health initiatives aimed at improving dementia care and awareness

Bottom-up Modeling

  • Collection of data on the number of dementia patients from healthcare facilities and clinics
  • Estimation of treatment costs based on pricing models from pharmaceutical companies and service providers
  • Volume x cost analysis to derive revenue projections for various treatment modalities

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating population aging, prevalence rates, and healthcare policy changes
  • Scenario modeling based on potential advancements in treatment options and healthcare infrastructure improvements
  • Baseline, optimistic, and pessimistic forecasts for the dementia treatment market through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare Providers120Neurologists, Geriatricians, General Practitioners
Pharmaceutical Companies70Product Managers, Market Access Specialists
Caregiver Insights60Family Caregivers, Professional Caregivers
Patient Advocacy Groups40Advocacy Leaders, Support Group Coordinators
Health Policy Experts40Health Economists, Policy Analysts

Frequently Asked Questions

What is the current value of the Saudi Arabia Dementia Treatment Market?

The Saudi Arabia Dementia Treatment Market is valued at approximately USD 70 million, reflecting a five-year historical analysis. This growth is attributed to the increasing prevalence of dementia, heightened awareness of mental health, and advancements in treatment options.

Which cities are key players in the Saudi Arabia Dementia Treatment Market?

What government initiatives support dementia care in Saudi Arabia?

What are the main types of dementia treated in Saudi Arabia?

Other Regional/Country Reports

Indonesia Dementia Treatment Market

Malaysia Dementia Treatment Market

KSA Dementia Treatment Market

APAC Dementia Treatment Market

SEA Dementia Treatment Market

Vietnam Dementia Treatment Market

Other Adjacent Reports

Egypt Alzheimers Disease Treatment Market

Philippines Vascular Dementia Treatment Market

Malaysia Lewy Body Dementia Treatment Market

Germany Frontotemporal Dementia Treatment Market

Oman Parkinsons Disease Dementia Treatment Market

Kuwait Neurological Disorders Market

UAE Geriatric Care Services Market

Singapore Telemedicine Solutions Market

Mexico Pharmacological Treatments Market

KSA Caregiver Support Programs Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022